000 | 00908 a2200253 4500 | ||
---|---|---|---|
005 | 20250517193751.0 | ||
264 | 0 | _c20190118 | |
008 | 201901s 0 0 eng d | ||
022 | _a1527-3792 | ||
024 | 7 |
_a10.1016/j.juro.2017.09.134 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLaguna, M Pilar | |
245 | 0 | 0 |
_aRe: A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. _h[electronic resource] |
260 |
_bThe Journal of urology _c01 2018 |
||
300 |
_a23-25 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 | _aCarcinoma, Renal Cell |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKidney Neoplasms |
650 | 0 | 4 | _aPyrroles |
650 | 0 | 4 | _aSunitinib |
773 | 0 |
_tThe Journal of urology _gvol. 199 _gno. 1 _gp. 23-25 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.juro.2017.09.134 _zAvailable from publisher's website |
999 |
_c27956891 _d27956891 |